Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice

Arthritis and Rheumatism

Volumn 65, Issue 12, 2013, Pages 3228-3238

  Yin, Hongen ^a   Cabrera Perez, Javier ^a   Lai, Zhenan ^a   Michael, Drew ^a   Weller, Melodie ^a   Swaim, William D ^a   Liu, Xibao ^a   Catalán, Marcelo A ^a   Rocha, Eduardo M ^a   Ismail, Nevien ^a   Afione, Sandra ^a   Rana, Noreen A ^a   Di Pasquale, Giovanni ^a   Alevizos, Ilias ^a   Ambudkar, Indu ^a   Illei, Gabor G ^a,b   Chiorini, John A ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LACRIMAL GLAND DISEASE; MINOR SALIVA GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; SALIVATION; SJOEGREN SYNDROME;

ANIMALS; AUTOANTIBODIES; BONE MORPHOGENETIC PROTEIN 6; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; LACRIMAL APPARATUS; MICE; MICE, INBRED C57BL; SALIVARY GLANDS; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 84889026059     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38123     Document Type: Article

References (43)

1. Fox RI,. Sjögren's syndrome. Lancet 2005; 366: 321-31.
2. Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, et al. Primary Sjögren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 2009; 7: 46.
3. Nikolov NP, Illei GG,. Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 2009; 21: 465-70.
4. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
5. Shippy R, Fulmer-Smentek S, Jensen RV, Jones WD, Wolber PK, Johnson CD, et al. Using RNA sample titrations to assess microarray platform performance and normalization techniques. Nat Biotechnol 2006; 24: 1123-31.
6. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-7.
7. Do JH, Choi DK,. Normalization of microarray data: single-labeled and dual-labeled arrays. Mol Cells 2006; 22: 254-61.
8. Zahurak M, Parmigiani G, Yu W, Scharpf RB, Berman D, Schaeffer E, et al. Pre-processing Agilent microarray data. BMC Bioinformatics 2007; 8: 142.
9. Li JZ, Li H, Hankins GR, Lieu AS, Noh E, Jacobson L, et al. Different osteogenic potentials of recombinant human BMP-6 adeno-associated virus and adenovirus in two rat strains. Tissue Eng 2006; 12: 209-19.
10. Rocha EM, Di Pasquale G, Riveros PP, Quinn K, Handelman B, Chiorini JA,. Transduction, tropism, and biodistribution of AAV vectors in the lacrimal gland. Invest Ophthalmol Vis Sci 2011; 52: 9567-72.
11. Vosters JL, Yin H, Roescher N, Kok MR, Tak PP, Chiorini JA,. Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome. Arthritis Res Ther 2009; 11: R189.
12. Katano H, Kok MR, Cotrim AP, Yamano S, Schmidt M, Afione S, et al. Enhanced transduction of mouse salivary glands with AAV5-based vectors. Gene Ther 2006; 13: 594-601.
13. Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, et al. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. Arthritis Rheum 2009; 60: 3633-41.
14. Yin H, Vosters JL, Roescher N, D'Souza A, Kurien BT, Tak PP, et al. Location of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome. PLoS One 2011; 6: e18003.
15. Yin H, Nguyen CQ, Samuni Y, Uede T, Peck AB, Chiorini JA,. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Arthritis Res Ther 2012; 14: R40.
16. Roescher N, Lodde BM, Vosters JL, Tak PP, Catalan MA, Illei GG, et al. Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome. Oral Dis 2012; 18: 96-106.
17. Liu X, Bandyopadhyay BC, Nakamoto T, Singh B, Liedtke W, Melvin JE, et al. A role for AQP5 in activation of TRPV4 by hypotonicity: concerted involvement of AQP5 and TRPV4 in regulation of cell volume recovery. J Biol Chem 2006; 281: 15485-95.
18. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI,. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005; 52: 1534-44.
19. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M, Pollanen P, et al. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjögren's syndrome. Rheumatology (Oxford) 2004; 43: 1476-9.
20. Petrek M, Cermakova Z, Hutyrova B, Micekova D, Drabek J, Rovensky J, et al. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2002; 20: 701-3.
21. Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, et al. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis Rheum 2009; 60: 1991-7.
22. Blessing M, Schirmacher P, Kaiser S,. Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 1996; 135: 227-39.
23. Chiorini JA, Cihakova D, Ouellette CE, Caturegli P,. Sjögren syndrome: advances in the pathogenesis from animal models. J Autoimmun 2009; 33: 190-6.
24. Humphreys-Beher MG, Peck AB,. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch Oral Biol 1999; 44 Suppl 1: S21-5.
25. Blessing M, Nanney LB, King LE, Hogan BL,. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-β related transgene. Teratog Carcinog Mutagen 1995; 15: 11-21.
26. Ma T, Song Y, Gillespie A, Carlson EJ, Epstein CJ, Verkman AS,. Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels. J Biol Chem 1999; 274: 20071-4.
27. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP,. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009; 41: 478-81.
28. Andriopoulos B Jr, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009; 41: 482-7.
29. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002; 99: 4596-601.
30. Lundstrom IM, Lindstrom FD,. Iron and vitamin deficiencies, endocrine and immune status in patients with primary Sjögren's syndrome. Oral Dis 2001; 7: 144-9.
31. Wach S, Schirmacher P, Protschka M, Blessing M,. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members. Oncogene 2001; 20: 7761-9.
32. Okada Y, Maeno E,. Apoptosis, cell volume regulation and volume-regulatory chloride channels. Comp Biochem Physiol A Mol Integr Physiol 2001; 130: 377-83.
33. Melvin JE, Yule D, Shuttleworth T, Begenisich T,. Regulation of fluid and electrolyte secretion in salivary gland acinar cells. Annu Rev Physiol 2005; 67: 445-69.
34. Langelueddecke C, Jakab M, Ketterl N, Lehner L, Hufnagl C, Schmidt S, et al. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions. Cell Physiol Biochem 2012; 29: 75-86.
35. - exchange. Am J Physiol 1984; 246: R735-40.
36. Tinel H, Kinne-Saffran E, Kinne RK,. Calcium signalling during RVD of kidney cells. Cell Physiol Biochem 2000; 10: 297-302.
37. Steinfeld S, Cogan E, King LS, Agre P, Kiss R, Delporte C,. Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients. Lab Invest 2001; 81: 143-8.
38. Shen GQ, Ojo-Amaize EA, Agopian MS, Peter JB,. Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity. Clin Diagn Lab Immunol 1996; 3: 162-6.
39. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002; 109: 59-68.
40. Green JE, Hinrichs SH, Vogel J, Jay G,. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature 1989; 341: 72-4.
41. Ittah M, Miceli-Richard C, Gottenberg JE, Sellam J, Lepajolec C, Mariette X,. B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation. Eur J Immunol 2009; 39: 1271-9.
42. Triantafyllopoulou A, Moutsopoulos HM,. Autoimmunity and coxsackievirus infection in primary Sjögren's syndrome. Ann N Y Acad Sci 2005; 1050: 389-96.
43. Beckham JD, Tuttle K, Tyler KL,. Reovirus activates transforming growth factor β and bone morphogenetic protein signaling pathways in the central nervous system that contribute to neuronal survival following infection. J Virol 2009; 83: 5035-45.